244 related articles for article (PubMed ID: 14514646)
1. Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy.
Kitada M; Koya D; Sugimoto T; Isono M; Araki S; Kashiwagi A; Haneda M
Diabetes; 2003 Oct; 52(10):2603-14. PubMed ID: 14514646
[TBL] [Abstract][Full Text] [Related]
2. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
Koya D; Jirousek MR; Lin YW; Ishii H; Kuboki K; King GL
J Clin Invest; 1997 Jul; 100(1):115-26. PubMed ID: 9202063
[TBL] [Abstract][Full Text] [Related]
3. PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes.
Liu Y; Lei S; Gao X; Mao X; Wang T; Wong GT; Vanhoutte PM; Irwin MG; Xia Z
Clin Sci (Lond); 2012 Feb; 122(4):161-73. PubMed ID: 21892921
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine stimulates phosphorylation of NADPH oxidase p47phox and p67phox subunits in monocytes via protein kinase Cbeta activation.
Siow YL; Au-Yeung KK; Woo CW; O K
Biochem J; 2006 Aug; 398(1):73-82. PubMed ID: 16626305
[TBL] [Abstract][Full Text] [Related]
5. NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney.
Zhu K; Kakehi T; Matsumoto M; Iwata K; Ibi M; Ohshima Y; Zhang J; Liu J; Wen X; Taye A; Fan C; Katsuyama M; Sharma K; Yabe-Nishimura C
Free Radic Biol Med; 2015 Jun; 83():21-30. PubMed ID: 25701431
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
[TBL] [Abstract][Full Text] [Related]
7. High glucose-suppressed endothelin-1 Ca2+ signaling via NADPH oxidase and diacylglycerol-sensitive protein kinase C isozymes in mesangial cells.
Hua H; Munk S; Goldberg H; Fantus IG; Whiteside CI
J Biol Chem; 2003 Sep; 278(36):33951-62. PubMed ID: 12821678
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species, PKC-beta1, and PKC-zeta mediate high-glucose-induced vascular endothelial growth factor expression in mesangial cells.
Xia L; Wang H; Munk S; Frecker H; Goldberg HJ; Fantus IG; Whiteside CI
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1280-8. PubMed ID: 17711990
[TBL] [Abstract][Full Text] [Related]
9. Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor.
Koike N; Takamura T; Kaneko S
Life Sci; 2007 Apr; 80(18):1721-8. PubMed ID: 17346751
[TBL] [Abstract][Full Text] [Related]
10. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse.
Liu GC; Fang F; Zhou J; Koulajian K; Yang S; Lam L; Reich HN; John R; Herzenberg AM; Giacca A; Oudit GY; Scholey JW
Diabetologia; 2012 Sep; 55(9):2522-32. PubMed ID: 22653270
[TBL] [Abstract][Full Text] [Related]
11. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation.
Quagliaro L; Piconi L; Assaloni R; Martinelli L; Motz E; Ceriello A
Diabetes; 2003 Nov; 52(11):2795-804. PubMed ID: 14578299
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor.
Ishii H; Jirousek MR; Koya D; Takagi C; Xia P; Clermont A; Bursell SE; Kern TS; Ballas LM; Heath WF; Stramm LE; Feener EP; King GL
Science; 1996 May; 272(5262):728-31. PubMed ID: 8614835
[TBL] [Abstract][Full Text] [Related]
13. Effects of an oral adsorbent on oxidative stress and fibronectin expression in experimental diabetic nephropathy.
Lee SH; Nam BY; Kang EW; Han SH; Li JJ; Kim DH; Kim SH; Kwak SJ; Park JT; Chang TI; Yoo TH; Han DS; Kang SW
Nephrol Dial Transplant; 2010 Jul; 25(7):2134-41. PubMed ID: 20157172
[TBL] [Abstract][Full Text] [Related]
14. The PKCβ-p66shc-NADPH oxidase pathway plays a crucial role in diabetic nephropathy.
Cheng YS; Chao J; Chen C; Lv LL; Han YC; Liu BC
J Pharm Pharmacol; 2019 Mar; 71(3):338-347. PubMed ID: 30417389
[TBL] [Abstract][Full Text] [Related]
15. Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats.
Soetikno V; Watanabe K; Sari FR; Harima M; Thandavarayan RA; Veeraveedu PT; Arozal W; Sukumaran V; Lakshmanan AP; Arumugam S; Suzuki K
Mol Nutr Food Res; 2011 Nov; 55(11):1655-65. PubMed ID: 22045654
[TBL] [Abstract][Full Text] [Related]
16. A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition.
Tuttle KR; Anderson PW
Am J Kidney Dis; 2003 Sep; 42(3):456-65. PubMed ID: 12955673
[TBL] [Abstract][Full Text] [Related]
17. Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes.
Graham S; Gorin Y; Abboud HE; Ding M; Lee DY; Shi H; Ding Y; Ma R
Am J Physiol Cell Physiol; 2011 Aug; 301(2):C304-15. PubMed ID: 21525431
[TBL] [Abstract][Full Text] [Related]
18. Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha.
Venugopal SK; Devaraj S; Yang T; Jialal I
Diabetes; 2002 Oct; 51(10):3049-54. PubMed ID: 12351446
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C delta is required for p47phox phosphorylation and translocation in activated human monocytes.
Bey EA; Xu B; Bhattacharjee A; Oldfield CM; Zhao X; Li Q; Subbulakshmi V; Feldman GM; Wientjes FB; Cathcart MK
J Immunol; 2004 Nov; 173(9):5730-8. PubMed ID: 15494525
[TBL] [Abstract][Full Text] [Related]
20. Effects of NADPH oxidase inhibitor in diabetic nephropathy.
Asaba K; Tojo A; Onozato ML; Goto A; Quinn MT; Fujita T; Wilcox CS
Kidney Int; 2005 May; 67(5):1890-8. PubMed ID: 15840036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
